Vital Signs - The Global Market for Type 2 Diabetes Therapeutics

Vital Signs - The Global Market for Type 2 Diabetes Therapeutics

RELEASE DATE
30-Sep-2013
REGION
North America
Research Code: 9A35-00-09-00-00
SKU: LS00229-NA-MR_17559

$450.00

Special Price $337.50 save 25 %

In stock
SKU
LS00229-NA-MR_17559

$450.00

$337.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This issue of Vital Signs, released on September 30, 2013, provides a market overview and drug pipeline analysis of Type 2 diabetes therapeutics.

Additionally, a company spotlight is provided for Trovagene in San Diego, CA. The company has a proprietary transrenal nucleic acid platform with the potential to deliver superior molecular diagnostics in urine.

Table of Contents

This week's issue

Related Research
This issue of Vital Signs, released on September 30, 2013, provides a market overview and drug pipeline analysis of Type 2 diabetes therapeutics. Additionally, a company spotlight is provided for Trovagene in San Diego, CA. The company has a proprietary transrenal nucleic acid platform with the potential to deliver superior molecular diagnostics in urine.
More Information
No Index Yes
Podcast No
Author Deborah Toscano
WIP Number 9A35-00-09-00-00
Is Prebook No